Danny McAuley
Professor Danny McAuley is a Professor of Intensive Care Medicine at the Wellcome-Wolfson Institute for Experimental Medicine, and a Consultant in Intensive Care Medicine at the Royal Victoria Hospital, Belfast. His other roles include Co-Director of Research for the UK Intensive Care Society and Director for MRC / NIHR Efficacy and Mechanism Evaluation programme
His work is currently focused on running important clinical trials aimed at improving the treatment and patient outcomes for critically ill COVID19 patients. One is a collaborative project between Queen’s and the University of Warwick that is testing the efficacy of non-invasive interventions at an earlier stage in disease progression as an effective alternative to using ventilators for COVID19 patients.
A second clinical trial is testing a novel cell therapy approach whereby cells derived from human tissues are being used to treat lung injury in patients with ARDS caused by COVID19. It is hoped that this approach will rectify the underlying causes of serious lung damage.
His work is currently focused on running important clinical trials aimed at improving the treatment and patient outcomes for critically ill COVID19 patients. One is a collaborative project between Queen’s and the University of Warwick that is testing the efficacy of non-invasive interventions at an earlier stage in disease progression as an effective alternative to using ventilators for COVID19 patients.
A second clinical trial is testing a novel cell therapy approach whereby cells derived from human tissues are being used to treat lung injury in patients with ARDS caused by COVID19. It is hoped that this approach will rectify the underlying causes of serious lung damage.
Country:
UK